A Case Series Study of Airway Pressure Release Ventilation in Patients with Intracranial Pathologies and Acute Respiratory Failure
Journal of Intensive Care Medicine · 2025
DOI: 10.1177/08850666251320550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intensive Care Medicine, 2025. Verfasst von Leon Schmidt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Continuous Positive Airway Pressure, Respiratory Insufficiency. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Airway Pressure Release Ventilation (APRV) is an alternate mode of ventilation in acute respiratory failure (ARF), but there is inconsistent data to support its use over other modes of ventilation. Because of increased intrathoracic pressure for most of the respiratory cycle, a negative impact of APRV on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) has been hypothesized. We evaluated the effects of APRV ventilation, with particular attention to ICP, CPP and ICP-directed therapy, in a real-world cohort of neuro-ICU patients.
Methods
Retrospective single-center analysis from January 2021 to December 2023 of neurosurgical ICU patients with ICP monitoring. APRV was used as a rescue mode at the physician's discretion when the Horovitz index (PaO 2 /FIO 2 ratio) fell below 150 despite optimized conventional ventilation.
Results
Between 2021 and 2023, APRV was utilized in 29 patients undergoing a total of 60 episodes. Forty patients (66.7%) were female, median age was 49.5 (Q1 34; Q3 61.25) years. After transition to APRV, mean FiO2 decreased by 4.3% (t = 3.5, p < .001) and mean PaO2 increased by 22.7 mm Hg (t = 4.2, p < .001). The Horovitz index improved by 44.6 mm Hg (t = 4.9, p < .001). Mean compliance did not differ after transition to APRV (−1.5 ml/mbar, t = −0.9, p = .4). During the APRV episode, mean ICP was 1.2 mm Hg lower (t = 2.6, p = .01), while mean CPP was 1.6 mm Hg higher (t = −0.9, p = .4) and the intensity of ICP-directed therapy (TIL) was significantly lower (X 2 = 92.771, p < .001).
Conclusion
APRV was hemodynamically tolerated in 29 out of 33 patients, and was safe with regard to ICP, CPP, and the intensity of ICP-directed therapy. Oxygenation was increased by APRV. 4 out of 33 patients would not tolerate APRV for hemodynamic reasons, APRV therefore was stopped immediately.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.
- Respiratory Therapy Services, University of Virginia Medical Center, Charlottesville, Virginia, USA.
ORCID-Profile: Leon Schmidt, Florian Ringel, Thomas Kerz
Zitieren
APA
Schmidt, L., Lamb, K., Jankovic, D., Kalasauskas, D., Kosterhon, M., Ringel, F., & Kerz, T. (2025). A Case Series Study of Airway Pressure Release Ventilation in Patients with Intracranial Pathologies and Acute Respiratory Failure. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666251320550
Vancouver
Schmidt L, Lamb K, Jankovic D, Kalasauskas D, Kosterhon M, Ringel F, et al. A Case Series Study of Airway Pressure Release Ventilation in Patients with Intracranial Pathologies and Acute Respiratory Failure. Journal of Intensive Care Medicine. 2025. doi:10.1177/08850666251320550
BibTeX
@article{Schmidt2025,
author = {Schmidt, Leon and Lamb, Keith and Jankovic, Dragan and Kalasauskas, Darius and Kosterhon, Michael and Ringel, Florian and Kerz, Thomas},
title = {A Case Series Study of Airway Pressure Release Ventilation in Patients with Intracranial Pathologies and Acute Respiratory Failure},
journal = {Journal of Intensive Care Medicine},
year = {2025},
doi = {10.1177/08850666251320550}
}
EUVIMED